Cargando…

EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update

We have previously described the role played by toxic-metal burdens in the etiology of neurodegenerative diseases (ND). We herein report an updated evaluation of toxic-metal burdens in human subjects affected or not affected by ND or other chronic diseases. Each subject underwent a chelation test wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fulgenzi, Alessandro, Vietti, Daniele, Ferrero, Maria Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460255/ https://www.ncbi.nlm.nih.gov/pubmed/32756375 http://dx.doi.org/10.3390/biomedicines8080269

Ejemplares similares

EDTA Chelation Therapy for the Treatment of Neurotoxicity
por: Fulgenzi, Alessandro, et al.
Publicado: (2019)

The usefulness of chelation therapy for the remission of symptoms caused by previous treatment with mercury-containing pharmaceuticals: a case report
por: Corsello, Serafina, et al.
Publicado: (2009)

Neuron Protection by EDTA May Explain the Successful Outcomes of Toxic Metal Chelation Therapy in Neurodegenerative Diseases
por: Ferrero, Maria Elena
Publicado: (2022)

Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment
por: Fulgenzi, Alessandro, et al.
Publicado: (2014)

Rationale for the Successful Management of EDTA Chelation Therapy in Human Burden by Toxic Metals
por: Ferrero, Maria Elena
Publicado: (2016)

Aluminium Involvement in Neurotoxicity
por: Fulgenzi, Alessandro, et al.
Publicado: (2014)

Protective effect of EDTA preadministration on renal ischemia
por: Foglieni, Chiara, et al.
Publicado: (2006)

EDTA chelation therapy for cardiovascular disease: a systematic review
por: Seely, Dugald MR, et al.
Publicado: (2005)

Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results
por: Vezzoli, Alessandra, et al.
Publicado: (2023)

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases
por: Nuñez, Marco T., et al.
Publicado: (2018)

Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016)

New Treatment for Band Keratopathy: Superficial Lamellar Keratectomy, EDTA Chelation and Amniotic Membrane Transplantation
por: Kwon, Young Sam, et al.
Publicado: (2004)

Erlotinib-associated severe bilateral recalcitrant keratouveitis after corneal EDTA chelation
por: Zhou, Zimei, et al.
Publicado: (2016)

Dicopper(II)-EDTA Chelate as a Bicephalic Receptor Model for a Synthetic Adenine Nucleoside
por: García-Rubiño, María Eugenia, et al.
Publicado: (2021)

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases
por: Ben-Shushan, Shira, et al.
Publicado: (2021)

Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease
por: Karamched, Saketh R., et al.
Publicado: (2019)

Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
por: Sales, Thais A., et al.
Publicado: (2019)

Efficacy of EDTA and HEDP Chelators in the Removal of Mature Biofilm of Enterococcus faecalis by PUI and XPF File Activation
por: Álvarez-Sagües, Alejandro, et al.
Publicado: (2021)

A Chelating Resin of EDTA-Type Modified Cross-Linking Polystyrene to Preconcentrate Trace Metals for Seawater Detection
por: Li, Chao, et al.
Publicado: (2022)

Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy
por: Garringer, Holly J., et al.
Publicado: (2016)

Methylxanthines and Neurodegenerative Diseases: An Update
por: Janitschke, Daniel, et al.
Publicado: (2021)

Beyond Chelation: EDTA Tightly Binds Taq DNA Polymerase, MutT and dUTPase and Directly Inhibits dNTPase Activity
por: Lopata, Anna, et al.
Publicado: (2019)

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline
por: Maeda, Yorinobu, et al.
Publicado: (2023)

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?
por: Ward, Roberta J., et al.
Publicado: (2021)

Ozonated autohemotherapy: protection of kidneys from ischemia in rats subjected to unilateral nephrectomy
por: Foglieni, Chiara, et al.
Publicado: (2011)

The Role of Vitamins in Neurodegenerative Disease: An Update
por: Rai, Sachchida Nand, et al.
Publicado: (2021)

Extracellular Vesicles in Neurodegenerative Diseases: An Update
por: Sigdel, Smara, et al.
Publicado: (2023)

Using substantial reductant concentration with chelation therapy to enhance small aggregate dispersal, iron mobilization, and its clearance in neurodegenerative diseases
por: Muhoberac, Barry B.
Publicado: (2022)

EDTA as a legacy soil chelatant: a comparative study to a more environmentally sensitive alternative for metal removal by Pistia stratiotes L.
por: Lebrun, Manhattan, et al.
Publicado: (2023)

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council
por: Zoccali, Carmine, et al.
Publicado: (2018)

Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease
por: Brazier, Marcus W., et al.
Publicado: (2014)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Mn bioavailability by polarized Caco-2 cells: comparison between Mn gluconate and Mn oxyprolinate
por: Foglieni, Chiara, et al.
Publicado: (2011)

Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial
por: Avila, Maria D., et al.
Publicado: (2014)

Androgen Therapy in Neurodegenerative Diseases
por: Bianchi, Vittorio Emanuele, et al.
Publicado: (2020)

Sirtuins in neurodegenerative diseases: an update on potential mechanisms
por: Min, Sang-Won, et al.
Publicado: (2013)

SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19
por: Dakal, Tikam Chand
Publicado: (2021)

Correction to: EDTA as a legacy soil chelatant: a comparative study to a more environmentally sensitive alternative for metal removal by Pistia stratiotes L.
por: Lebrun, Manhattan, et al.
Publicado: (2023)

Applying EDTA in Chelating Excess Metal Ions to Improve Downstream DNA Recovery from Mine Tailings for Long-Read Amplicon Sequencing of Acidophilic Fungi Communities
por: Nkuna, Rosina, et al.
Publicado: (2022)

Next Congresses of the ERA-EDTA
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uk3vcagcbt00rrjrmpolpb3drr